NIH-funded research R01 grant

Improving detection of tuberculosis infections

Official title: Ultrasensitive detection of Mycobacterium tuberculosis infection

Funded at Texas A&m University Health Science Ctr · NIH-10944723 · Data updated 2026-11-12

This study is working on new imaging tools to help doctors find tuberculosis (TB) faster and more accurately, so they can see how well treatments and vaccines are working in real-time.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionTexas A&m University Health Science Ctr
NIH-funded
Lab location1 site (College Station, United States)
Project startJuly 22, 2024
Project endJune 30, 2029
Funding year2024
Award (this year)$737,342
NIH project number1R01AI186092-01
Project IDNIH-10944723 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals at risk of tuberculosis infection or those already diagnosed with TB.

Less likely to help

Patients with non-tuberculosis related infections or conditions will likely not benefit from this research.

What this research studies

This research focuses on developing advanced imaging technologies to detect Mycobacterium tuberculosis, the bacteria responsible for tuberculosis (TB). By enhancing the sensitivity of these imaging methods, the project aims to allow for quicker and more accurate evaluation of TB infections in various tissues. This could enable healthcare providers to assess the effectiveness of treatments and vaccines in real-time, significantly speeding up the process compared to traditional methods. The approach involves using innovative imaging techniques that can track bacterial loads and infection dynamics more effectively.

Why it matters

Potential benefit: If successful, this research could lead to faster and more accurate diagnosis and treatment of tuberculosis, ultimately improving patient outcomes.

How similar studies have gone: Previous research has shown promise in using advanced imaging techniques for tracking infections, indicating potential success for this novel approach.

Where this research is happening

  • Texas A&m University Health Science Ctr
    College Station, United States
    Active

Researchers

  • Principal investigator: Cirillo, Jeffrey D. — Texas A&m University Health Science Ctr
  • Study coordinator: Cirillo, Jeffrey D.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.